anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

208,801-208,860 of 319,975

filter-aware
10
Uses a combination of a donut chart for ownership and bar/line charts for financial performance to discredit the target company.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · Agitate1 hit
11
Uses a 'Claim vs Reality' framework to discredit competitors' M&A strategies.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · Solution1 hit
12
Uses a hub-and-spoke style layout to position Nano Dimension as the superior option against two competitors.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · Solution1 hit
01
Slide 1
Nano Dimension | Results Presentation Deck | 18 slidesNano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Current State1 hit
02
Nano Dimension | Results Presentation Deck | 18 slidesNano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Current State1 hit
03
Nano Dimension | Results Presentation Deck | 18 slidesNano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Current State1 hit
04
Includes IFRS and non-IFRS financial metrics.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Current State1 hit
05
Includes non-IFRS adjustments and footnotes regarding reconciliation and expense exclusions.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Current StateLoop · Zoom In1 hit
06
Includes IFRS vs non-IFRS reconciliation notes.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Future VisionLoop · Zoom In1 hit
07
The chart includes a trend line and percentage growth annotations between periods.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Future Vision1 hit
08
The chart highlights Nano Dimension's superior performance (43%) compared to negative or low growth among peers.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Future Vision1 hit
09
The slide uses logos of acquired companies to represent the growth of the parent entity.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Future VisionLoop · Before After1 hit
10
The slide uses a bar chart to show revenue growth and a secondary callout box to compare against a competitor's performance.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Future VisionLoop · Before After1 hit
11
Nano Dimension | Results Presentation Deck | 18 slidesNano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Future Vision1 hit
12
The slide serves as a call to action for shareholders to tender their shares.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Future Vision1 hit
13
Nano Dimension | Results Presentation Deck | 18 slidesNano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Conclusion1 hit
14
Nano Dimension | Results Presentation Deck | 18 slidesNano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Conclusion1 hit
15
Standard financial disclosure slide defining non-GAAP/non-IFRS metrics.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Conclusion1 hit
16
Includes reconciliation for EBITDA, Adjusted EBITDA, Adjusted Gross Profit, and Net Cash used in operations.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Conclusion1 hit
17
The chart illustrates the ratio of cash balance to annual net cash used in operating activities, highlighting Nano Dimension's superior liquidity position.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Conclusion1 hit
18
Includes footnotes regarding IFRS reconciliation and specific line item definitions.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Conclusion1 hit
01
Slide 1
Features a 3D rendering of a synapse.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
02
NeuroSense Therapeutics | Investor Presentation Deck | 34 slidesNeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
03
The slide uses a standard drug development pipeline visualization.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
04
Includes a progress bar at the bottom indicating 'Intro' section.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a list of key benefits to summarize the product's market and clinical position.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
06
Includes a navigation bar at the bottom indicating the current section is 'PrimeC'.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
07
The slide uses a case study to validate the business/clinical model of combination therapies.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
08
The slide uses a bar chart to compare hazard ratios of multiple compounds against a vehicle control, with statistical significance markers.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
09
Uses a chain-link visual metaphor to represent the combination of two distinct therapeutic strategies.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
10
Includes a line chart showing PK data and a biological diagram illustrating the mechanism of action (blocking MDR-mediated efflux).NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
11
The chart highlights the synchronized peak at 5 hours for both active ingredients in the PrimeC formulation compared to reference compounds.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
12
The slide uses a biological process diagram to illustrate how PrimeC modulates microRNA regulation, TDP-43 aggregation, and cellular recycling.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
13
Includes a bar chart of motor performance and visual evidence of motor neuron recovery.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
14
Includes a progress bar at the bottom indicating the current section is 'Phase 2a Results'.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
15
The slide uses a comparative clinical trial analysis against a historical control database (PRO-ACT).NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
16
Includes a process diagram showing exosome extraction from blood samples.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
17
Data shows p-values of 0.005 and <0.001 for treated groups, indicating significant biomarker reduction.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
18
The slide uses a process-flow diagram to link trial results to the next phase of development.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
19
Includes a progress bar at the bottom indicating the current stage is Phase 2b.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
20
The slide uses a numbered list format to categorize four distinct patent filings.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
21
The slide uses a logo-grid layout to establish credibility through institutional and industry partnerships.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
22
The slide uses a color-coded legend for ALS, Alzheimer's, and Parkinson's.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
23
NeuroSense Therapeutics | Investor Presentation Deck | 34 slidesNeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
24
NeuroSense Therapeutics | Investor Presentation Deck | 34 slidesNeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
25
The slide includes a progress bar at the bottom indicating the current section is 'Summary'.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
26
The slide serves as a media/press coverage page, likely for an appendix.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
27
Includes stock price, market cap, cash position, and analyst coverage.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
28
Includes a team photo and a progress bar at the bottom indicating the current slide is the 'Summary' section.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
29
NeuroSense Therapeutics | Investor Presentation Deck | 34 slidesNeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
30
This is a highly emotional, narrative-driven slide used to ground the company's mission in a personal story.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
31
The chart shows a negative correlation trend line between TDP-43 change and ALSFRS-R slope.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
32
NeuroSense Therapeutics | Investor Presentation Deck | 34 slidesNeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
33
The slide serves as a press clipping or media coverage appendix.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
34
Includes a navigation bar at the bottom indicating the current section is 'Phase 2b'.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
01
Slide 1
Includes a footnote indicating the company was formerly known as Nexters.Nexters | Investor Presentation Deck | 19 slides · GDEV
Pitch deck Investor relations 1 hit
02
Nexters | Investor Presentation Deck | 19 slidesNexters | Investor Presentation Deck | 19 slides · GDEV
Pitch deck Investor relations 1 hit
03
Includes definitions for MPUs, ABPPU, Bookings, and Adjusted EBITDA.Nexters | Investor Presentation Deck | 19 slides · GDEV
Pitch deck Investor relations 1 hit
04
The slide uses a mix of logos, bar charts for financial/user growth, and a pie chart for platform split.Nexters | Investor Presentation Deck | 19 slides · GDEV
Pitch deck Investor relations 1 hit
05
The slide uses a grid of icons to highlight six key pillars of the company's competitive advantage.Nexters | Investor Presentation Deck | 19 slides · GDEV
Pitch deck Investor relations 1 hit